Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy

Clin Cancer Res. 2010 Oct 1;16(19):4695-701. doi: 10.1158/1078-0432.CCR-10-0356. Epub 2010 Aug 5.

Abstract

Wnt ligands are lipid-modified secreted glycoproteins that regulate embryonic development, cell fate specification, and the homeostasis of self-renewing adult tissues. In addition to its well-established role in thymocyte development, recent studies have indicated that Wnt/β-catenin signaling is critical for the differentiation, polarization, and survival of mature T lymphocytes. Here, we describe our current understanding of Wnt signaling in the biology of post-thymic T cells, and discuss how harnessing the Wnt/β-catenin pathway might improve the efficacy of vaccines, T-cell-based therapies, and allogeneic stem cell transplantation for the treatment of patients with cancer.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunity
  • Immunotherapy*
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Signal Transduction / immunology*
  • T-Lymphocytes / immunology*
  • Transplantation, Autologous
  • Wnt Proteins / immunology*
  • beta Catenin / immunology*

Substances

  • Wnt Proteins
  • beta Catenin